Clinical Trials
56 trialsTRACK
TargetCancer Foundation
A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy
M.D. Anderson Cancer Center
CUPem
Imperial College London
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord
M.D. Anderson Cancer Center
A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)
University of Texas Southwestern Medical Center
Cancer Genetic Testing in Ethnic Populations
Mayo Clinic
Sintilimab in Cancer of Unknown Primary
M.D. Anderson Cancer Center
FAPI PET RDRC
Jonsson Comprehensive Cancer Center
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
M.D. Anderson Cancer Center
NorCUP
Haukeland University Hospital
CAPTIV-8
British Columbia Cancer Agency
CUP
AHS Cancer Control Alberta
ACROPOLI
SOLTI Breast Cancer Research Group
VISIONARY
Peking University
OP-CUP
Rigshospitalet, Denmark
HARE-40
University of Southampton
AGNOSTOS
Fondazione del Piemonte per l'Oncologia
REFLECT
University Medical Center Groningen
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
Mayo Clinic
TOFFEE
University of Edinburgh
FAPI-CUP
Peter MacCallum Cancer Centre, Australia
Postoperative Pain, Why Still in Hospital and DAOH Following TORS for SCCUP & OSAS
Rigshospitalet, Denmark
PUTNET
Excel Diagnostics and Nuclear Oncology Center
Tissue-of-origin Directing Therapy in Patients With Cancer of Unknown Primary
Fudan University
Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin
Burzynski Research Institute
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
University of Chicago
CheCUP
University Hospital Heidelberg
GEFCAPI04
Gustave Roussy, Cancer Campus, Grand Paris
Elective Mucosal Irradiation in Head-and-Neck Cancer of Unknown Primary
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
EPAC
Stanford University
Irinotecan and Capecitabine in Treating Patients With Solid Tumors
Montefiore Medical Center
Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin
St. Jude Children's Research Hospital
Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary
Alliance for Clinical Trials in Oncology
Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
Alliance for Clinical Trials in Oncology
High-dose ICE With Amifostine
Dana-Farber Cancer Institute
Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer
University of Miami
Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary
Ohio State University Comprehensive Cancer Center
Comparing of Modified Wet Suction Technique and Dry Suction Technique for EUS-FNA of Solid Occupying Lesions
Huazhong University of Science and Technology
Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown Primary
Samsung Medical Center
Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin
Rutgers, The State University of New Jersey
Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary Tumor
Rigshospitalet, Denmark
Prospective Multi-center, Single Blinded, Randomized, Controlled Trial of EUS-FNB and EUS-FNA on Solid Occupying Lesion
Huazhong University of Science and Technology
Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site
SCRI Development Innovations, LLC
Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site
SCRI Development Innovations, LLC
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Dartmouth-Hitchcock Medical Center
Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer
Yale University
Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors
Memorial Sloan Kettering Cancer Center
Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site
SCRI Development Innovations, LLC
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.
Fox Chase Cancer Center